In addition, OS correlated with the patients aged ≥50 years (HR: 2.66, 95% CI: 1.42–4.96, p = 0.002), Grade III (HR: 1.89, 95% CI: 1.06–3.40, p = 0.032), stages III + IV (HR: 2.81, 95% CI: 1.62–4.89, p = 0.001) and higher expression of TMCC3 in tumor (HR: 2.92, 95% CI: 1.69–5.02, p = 0.001) (Table 2). Here, TMCC3 is linked to neoplasm.